Product Name |
Trandolaprilat D6 |
Alternate Names |
Trandolapril Stable Isotopes, Stable Isotopes of Trandolapril |
CAT No. |
CS-O-10095
|
CAS No. |
87679-71-8(Unlabeled) |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
408.52 g/mol |
Mol. For. |
C₂₂H₂₄D₆N₂O₅
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Trandolapril |
Therapeutic |
Anti-Hypertensives |
Smileys |
O=C(N1[C@](CCCC2)([H])[C@@]2([H])C[C@H]1C(O)=O)[C@H](C)N[C@H](C(O)=O)CC([2H])C(C([2H])=C3[2H])=C(C([2H])=C3[2H])[2H] |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Trandolaprilat D6 is a deuterium-labeled form of Trandolaprilat, a medication used to treat high blood pressure and heart failure. It is classified as an angiotensin-converting enzyme inhibitor (ACE inhibitor) that works by relaxing blood vessels, which helps to lower blood pressure and improve blood flow.
The chemical formula for Trandolaprilat D6 is C24H32D6N3O5, and its molecular weight is 448.6 g/mol. It is a white crystalline powder that is soluble in water and ethanol.
Trandolaprilat D6 is used in clinical research to study the pharmacokinetics and pharmacodynamics of Trandolaprilat in the body. Deuterium-labeled compounds like Trandolaprilat D6 are used as internal standards in mass spectrometry-based assays to accurately measure the concentration of drugs in biological samples.
The recommended dosage of Trandolaprilat for hypertension is 1mg to 4mg daily, while the dosage for heart failure is 0.5mg to 2mg daily. Trandolaprilat D6 should only be used under the direction of a healthcare provider and should not be used by individuals with a history of angioedema or hypersensitivity to ACE inhibitors.
In conclusion, Trandolaprilat D6 is an important tool for research and development in the pharmaceutical industry, allowing for accurate measurement of Trandolaprilat in biological samples and contributing to the development of effective treatments for hypertension and heart failure.